
A clinical trial to assess the immunogenicity and safety of Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine; VaxiFlu-STM) in healthy Indian adult population
Author(s) -
AH Kubavat,
Ravindra Mittal,
P. M. Patel,
DH Jarsaniya,
P. G. Pawar .
Publication year - 2011
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.81860
Subject(s) - medicine , immunogenicity , virology , pandemic , influenza vaccine , pandemic influenza , population , live attenuated influenza vaccine , influenza a virus subtype h5n1 , vaccination , h1n1 influenza , covid-19 , immunology , virus , environmental health , immune system , disease , infectious disease (medical specialty)
The pandemic of H1N1 2009 influenza has spread world over and low degree of virus transmission has continued in several regions of India.